Issue 22, 2019

Albumin enhances PTX delivery ability of dextran NPs and therapeutic efficacy of PTX for colorectal cancer

Abstract

To enhance the drug delivery capability of polysaccharides, a novel strategy was designed utilizing protein as a new party to assist the encapsulation and release of PTX. Herein, the BSA–PTX complex was first prepared, and aldehyde-dextran was then successfully cross-linked with BSA–PTX to obtain pH-sensitive Dex6k–BSA–PTX nanoparticles via the Schiff base reaction. With a size of 150 nm and high drug loading, the Dex6k–BSA–PTX NPs significantly prolonged the blood half-life of PTX and could be passively targeted to tumor tissues, with a significant inhibition of the growth of tumor cells in vivo and in vitro.

Graphical abstract: Albumin enhances PTX delivery ability of dextran NPs and therapeutic efficacy of PTX for colorectal cancer

Supplementary files

Article information

Article type
Paper
Submitted
26 jan 2019
Accepted
19 apr 2019
First published
22 apr 2019

J. Mater. Chem. B, 2019,7, 3537-3545

Albumin enhances PTX delivery ability of dextran NPs and therapeutic efficacy of PTX for colorectal cancer

X. Zhang, R. Zhang, J. Huang, M. Luo, X. Chen, Y. Kang and J. Wu, J. Mater. Chem. B, 2019, 7, 3537 DOI: 10.1039/C9TB00181F

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements